Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients

Sadegh Safaei^{1

2

3}, Masoud Karimi-Googheri^{1

2

4}

Affiliations

¹ Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
² Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
³ Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
⁴ Department of Clinical Laboratory, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran.

Comment

Sadegh Safaei et al. Viral Immunol. 2021 Jun.

. 2021 Jun;34(5):361-362.

doi: 10.1089/vim.2020.0074. Epub 2020 Oct 1.

Sadegh Safaei^{1

2

3}, Masoud Karimi-Googheri^{1

2

4}

¹ Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
² Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
³ Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
⁴ Department of Clinical Laboratory, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran.

No abstract available

Comment on

Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
Conti P, Younes A. Conti P, et al. J Biol Regul Homeost Agents. 2020 March-April,;34(2):339-343. doi: 10.23812/Editorial-Conti-3. J Biol Regul Homeost Agents. 2020. PMID: 32253888